Crossmark

Clinical efficacy and safety of flumatinib versus dasatinib combined with multi-drug chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia

Crossref DOI link: https://doi.org/10.1016/j.htct.2023.12.005

Published Print: 2024-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Liu, Qian https://orcid.org/0009-0001-7609-7860
Bian, Tie Rong

Li, Zhi Yuan

Xing, Hong Yun
Funding

Funding for this research was provided by:

Sichuan Province Science and Technology Support Program
License Information

Text and Data Mining valid from 2024-12-01

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2024-01-30
More Information

This article is maintained by: Elsevier

Article Title: Clinical efficacy and safety of flumatinib versus dasatinib combined with multi-drug chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2023.12.005

Content Type: article

Copyright: © 2024 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below